Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 17, 2024

SELL
$0.17 - $1.19 $2,467 - $17,272
-14,515 Closed
0 $0
Q3 2022

Jul 17, 2024

BUY
$1.51 - $2.88 $10,796 - $20,592
7,150 Added 97.08%
14,515 $22.8 Million
Q1 2022

Jul 17, 2024

BUY
$2.0 - $4.9 $6,730 - $16,488
3,365 Added 84.13%
7,365 $17.2 Million
Q3 2021

Jul 17, 2024

SELL
$7.41 - $10.99 $257,571 - $382,012
-34,760 Reduced 89.68%
4,000 $30.5 Million
Q2 2021

Jul 17, 2024

BUY
$6.35 - $10.0 $232,460 - $366,080
36,608 Added 1701.12%
38,760 $4 Million
Q1 2021

Jul 17, 2024

BUY
$7.03 - $16.51 $7,030 - $16,510
1,000 Added 86.81%
2,152 $17.8 Million
Q3 2020

Jul 17, 2024

BUY
$6.17 - $18.82 $7,107 - $21,680
1,152 New
1,152 $12.8 Million

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.